{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:08:38Z","timestamp":1790809718409,"version":"4.1.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,18]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Endometriosis is a common benign disease in women of childbearing age, with a malignant change rate of about 1%. Endometriosis associated ovarian cancer (EAOC), which usually occurs in the ovaries, is a serious threat to women\u2019s health. Early identification of high-risk groups of EMs malignant transformation is of great significance for the prevention and treatment of EAOC. However, there is still a lack of specific and sensitive prediction factors. In recent years, scholars at home and abroad have used traditional statistical methods and machine learning to explore EAOC related prediction factors and prediction models. This paper mainly reviews and evaluates the diagnosis and prediction model of EAOC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Studies were identified by searching the CNKI, PubMed and Web of Science Core Collection, (WOSCC) till 2023, Data which met the inclusion criteria of clinical studies were evaluated about the quality. This paper analyzes and summarizes the prediction factors and prediction models in the literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>After screening, 7 relevant studies were finally obtained. Prediction factors included: age, menstruation, menopausal status, course of disease, infertility associated with endometriosis, history of single estrogen use during menopause, serological indexes: human epididymis protein 4, carbohydrate antigen 125(CA125), ovarian malignancy risk algorithm, indications for ultrasound examination: cyst shape, structure and blood flow signal, etc. Prediction models: Alignment diagram, Multivariate logistic regression model, Gail model, Gradient Boosting Decision Tree and Lasso-logistics regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Related models were in good agreement with the actual situation, and have good sensitivity and specificity. The relevant prediction factors and prediction models were summarized to provide reference and new thinking for the research of prediction models in the field of EAOC, in order to develop standardized long-term management strategies for high-risk groups of EAOC and realize the advance of the diagnosis threshold of patients with EAOC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040131","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T18:05:34Z","timestamp":1730138734000},"page":"e40131","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Research progress on correlative prediction factors and prediction models of endometriosis associated ovarian carcinoma"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8430-8562","authenticated-orcid":false,"given":"Jing","family":"Liu","sequence":"first","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ma","sequence":"additional","affiliation":[{"name":"West China Second University Hospital, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Jiang","sequence":"additional","affiliation":[{"name":"West China Second University Hospital, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xie","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMra1810764","article-title":"Endometriosis.","volume":"382","author":"Zondervan","year":"2020","journal-title":"N Engl J Med"},{"key":"R2-20250503","first-page":"282","article-title":"Clinical risk analysis of endometriosis malignancy.","volume":"53","author":"Zhengxing","year":"2018","journal-title":"Chin J Obstet Gynecol"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41746-022-00638-1","article-title":"Clinical use of artificial intelligence in endometriosis: a scoping review.","volume":"5","author":"Sivajohan","year":"2022","journal-title":"NPJ Digit Med"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41598-021-04637-2","article-title":"Machine learning algorithms as new screening approach for patients with endometriosis.","volume":"12","author":"Bendifallah","year":"2022","journal-title":"Sci Rep"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","article-title":"Association between endometriosis and risk of histological subtypes ofovarian cancer:a pooled analysis of case-control studies.","volume":"13","author":"Pearce","year":"2012","journal-title":"Lancet Oncol"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ygyno.2016.07.095","article-title":"Endometriosis and risks for ovarian, endometrial and breast cancers: a nationwide cohort study.","volume":"143","author":"Mogensen","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10552-017-0856-4","article-title":"Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses.","volume":"28","author":"Poole","year":"2017","journal-title":"Cancer Causes Control"},{"key":"R9-20250503","first-page":"7689","article-title":"Association between ovarian cancer and advanced endometriosis.","volume":"15","author":"Matalliotakis","year":"2018","journal-title":"Oncol Lett"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-3-030-38474-6_5","article-title":"Endometriosis and endometriosis-associated ovarian cancer (EAOC).","volume":"1242","author":"Pejovic","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/GRF.0000000000000320","article-title":"Endometriosis-associated ovarian cancers.","volume":"60","author":"Anglesio","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2018.12.015","article-title":"Endometriosis and cancer.","volume":"133","author":"Kajiyama","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.celrep.2018.07.037","article-title":"Clonal expansion and diversification of cancer-associated mutations in endometriosis and normal endometrium.","volume":"24","author":"Suda","year":"2018","journal-title":"Cell Rep"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10147-019-01536-5","article-title":"Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts.","volume":"25","author":"Murakami","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/jnci\/djz015","article-title":"The association between hysterectomy and ovarian cancer risk: a population-based record-linkage study.","volume":"111","author":"Dixon-Suen","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/path.4516","article-title":"Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden.","volume":"236","author":"Anglesio","year":"2015","journal-title":"J Pathol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00404-019-05358-8","article-title":"Endometriosis and risk of ovarian cancer: what do we know?","volume":"301","author":"Kr\u00e1l\u00ed\u010dkov\u00e1","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1186\/1471-2407-14-831","article-title":"An increasedrisk of epithelial ovarian cancer in Taiwanese women with a new surgicopathological diagnosis of endometriosis.","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Cancer"},{"key":"R19-20250503","first-page":"468","article-title":"A study on 23 cases of neoplasias arised from endometriosis (EM).","volume":"40","author":"Li","year":"2013","journal-title":"Fudan Univ J Med Sci"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejogrb.2014.11.029","article-title":"Predictive factors for the presence of malignant transformation of pelvic endometriosis.","volume":"185","author":"Kadan","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R21-20250503","first-page":"662","article-title":"Clinical characteristics and prognosis of patients with ovarian epithelial cancer with endometriosis.","volume":"28","author":"Xiaoxue","year":"2019","journal-title":"Prog Obstet Gynecol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"hoac009","DOI":"10.1093\/hropen\/hoac009","article-title":"ESHRE guideline: endometriosis.","volume":"2022","author":"Becker","year":"2022","journal-title":"Hum Reprod Open"},{"key":"R23-20250503","first-page":"27","article-title":"Malignant transformation of endometriosis.","volume":"57","author":"Chongdong","year":"2019","journal-title":"J Shandong Univ"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"107.e1","DOI":"10.1016\/j.ajog.2020.01.041","article-title":"Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study.","volume":"223","author":"Hermens","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R25-20250503","first-page":"193","article-title":"History, present situation and development of understanding of endometriosis.","volume":"36","author":"Jinghe","year":"2020","journal-title":"Chin J Pract Gynecol Obstet"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1007\/s00261-019-02309-4","article-title":"Endometriosis in the post-menopausal female: clinical presentation, imaging features, and management.","volume":"45","author":"Cope","year":"2020","journal-title":"Abdom Radiol (NY)"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/13697137.2018.1450855","article-title":"Postmenopausal endometriosis: drawing a clearer clinical picture.","volume":"21","author":"Tan","year":"2018","journal-title":"Climacteric"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejogrb.2007.06.017","article-title":"Ovarian endometrioma \u2013 risks factors of ovarian cancer development.","volume":"138","author":"Kobayashi","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1080\/00016340701619407","article-title":"Postmenopausal endometriosis.","volume":"86","author":"Oxholm","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/humupd\/7.1.15","article-title":"Endometriosis: candidate genes.","volume":"7","author":"Campbell","year":"2001","journal-title":"Hum Reprod Update"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2019.02.016","article-title":"Endometriosis-associated ovarian cancer: what have we learned so far?","volume":"493","author":"Herreros-Villanueva","year":"2019","journal-title":"Clin Chim Acta"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1067\/mob.2003.408","article-title":"Endometriosis and ovarian cancer: thoughts on shared pathophysiology.","volume":"189","author":"Ness","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.fertnstert.2004.02.109","article-title":"Ovarian cancer risk associated with varying causes of infertility.","volume":"82","author":"Brinton","year":"2004","journal-title":"Fertil Steril"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12672-018-0350-9","article-title":"The evolution of estrogen receptor signaling in the progression of endometriosis to endometriosis-associated ovarian cancer.","volume":"9","author":"Andersen","year":"2018","journal-title":"Horm Cancer"},{"key":"R35-20250503","first-page":"740","article-title":"Research progress of progesterone resistance in patients with endometriosis.","volume":"43","author":"Huancheng","year":"2023","journal-title":"Chin J Reprod Contracept"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1024\/0040-5930\/a001295","article-title":"Endometriose und klimakterisches syndrom [Endometriosis and menopause].","volume":"78","author":"Weber","year":"2021","journal-title":"Ther Umsch"},{"key":"R37-20250503","first-page":"585","article-title":"Advances in clinical research of endometriosis malignancy.","volume":"39","author":"Qiannan","year":"2017","journal-title":"Zhejiang Med J"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0037-1601398","article-title":"Biomarkers of pelvic endometriosis.","volume":"39","author":"Reis","year":"2017","journal-title":"Rev Bras Ginecol Obstet"},{"key":"R39-20250503","first-page":"1152","article-title":"Study on the relationship between malignant transformation of ovarian endometriosis and ovarian malignancy and prognostic factors.","volume":"14","author":"Yuhua","year":"2015","journal-title":"J Clin Exp Med"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijgo.2007.06.003","article-title":"Serum CA125 level before the development of ovarian cancer.","volume":"99","author":"Kobayashi","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.3892\/mmr.2015.4062","article-title":"Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125.","volume":"12","author":"Mckinnon","year":"2015","journal-title":"Mol Med Rep"},{"key":"R42-20250503","first-page":"245","article-title":"Diagnostic value of serum human epididymal protein 4 and glycochain antigen 125 in ovarian cancer.","volume":"31","author":"Xiaoli","year":"2017","journal-title":"J Chin Pract Diagn Ther"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/IGC.0000000000000804","article-title":"Diagnostic performance of risk of ovarian malignancy algorithm against ca125 and he4 in connection with ovarian cancer: a meta-analysis.","volume":"26","author":"Dayyani","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"R44-20250503","first-page":"901","article-title":"Risk factors of the malignant transformation of untreated ovarian endometriosis.","volume":"29","author":"Ting","year":"2020","journal-title":"Prog Obstet Gynecol"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2463\/mrms.mp.2016-0149","article-title":"Factors that differentiate between endometriosis-associated ovarian cancer and benign ovarian endometriosis with mural nodules.","volume":"17","author":"Tanase","year":"2018","journal-title":"Magn Reson Med Sci"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/aogs.13010","article-title":"Risk factors of epithelial ovarian carcinomas among women with endometriosis: a systematic review.","volume":"96","author":"Thomsen","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R47-20250503","first-page":"5775","article-title":"Risk factors and preventive measures of endometriosis related ovarian cancer.","volume":"33","author":"Rina","year":"2018","journal-title":"Matern Child Health Care China"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/gutjnl-2021-324191","article-title":"Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"R49-20250503","first-page":"230","article-title":"Construction and validation of endometriosis associated ovarian cancer risk model.","volume":"22","author":"Yan","year":"2022","journal-title":"J Evid Based Med"},{"key":"R50-20250503","first-page":"1","article-title":"Nomogram of clinical features of endometriosis-associated ovarian cancer.","volume":"44","author":"Wang","year":"2023","journal-title":"J Air Force Med Univ"},{"key":"R51-20250503","first-page":"394","article-title":"Establishment of a Nomogram for predicting risk of malignant transformation of perimenopausal endometriosis.","volume":"58","author":"Wang","year":"2023","journal-title":"J Zhengzhou Univ (Medical Sciences)"},{"key":"R52-20250503","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2463\/mrms.mp.2016-0028","article-title":"Transverse relaxation rate of cyst fluid can predict malignant transformation of ovarian endometriosis.","volume":"16","author":"Yoshimoto","year":"2017","journal-title":"Magn Reson Med Sci"},{"key":"R53-20250503","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.3390\/cancers13153829","article-title":"A novel predictive tool for discriminating endometriosis associated ovarian cancer from ovarian endometrioma: the r2 predictive index.","volume":"13","author":"Kawahara","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R54-20250503","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.","volume":"81","author":"Gail","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"R55-20250503","first-page":"1391","article-title":"The absolute risk prediction model for malignant endometriosis in the next 5 years.","volume":"30","author":"Wenting","year":"2022","journal-title":"Chin J Birth Health Hered"},{"key":"R56-20250503","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/aogs.14462","article-title":"The application of risk models based on machine learning to predict endometriosis-associated ovarian cancer in patients with endometriosis.","volume":"101","author":"Chao","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R57-20250503","doi-asserted-by":"crossref","first-page":"102296","DOI":"10.1016\/j.pmedr.2023.102296","article-title":"Development of prediction model to estimate future risk of ovarian lesions: a multi-center retrospective study.","volume":"35","author":"Jing","year":"2023","journal-title":"Prev Med Rep"},{"key":"R58-20250503","first-page":"1","article-title":"Influence of the gut microbiota on endometriosis: potential role of chenodeoxycholic acid and its derivatives.","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:18:47Z","timestamp":1746317927000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":58,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040131","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}